What Is Neurohypophysial Hormone? Definition and What Research Reports

Definition

Neurohypophysial hormone is a collective term for the peptide hormones released into the circulation from the neurohypophysis — the posterior lobe of the pituitary gland. In mammals the term covers two molecules: vasopressin (also called antidiuretic hormone) and oxytocin. Both are nonapeptides (nine amino acids), both are synthesised in magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei, and both reach the bloodstream from axon terminals in the posterior pituitary rather than from a glandular epithelium. The label therefore describes an anatomical route of release and a structural family, not a single compound; in non-mammalian vertebrates the same family is represented by homologues such as vasotocin, isotocin and mesotocin.

What Class of Molecule Is It?

Neurohypophysial hormones are cyclic nonapeptides. Each contains a ring closed by a disulfide bridge between two cysteine residues and a short amidated tail, and the family is conventionally split into two lineages: a vasopressin/vasotocin-like line and an oxytocin/isotocin/mesotocin-like line, distinguished by the residue occupying position 8 of the peptide. Because the peptides are short, conserved and structurally constrained, they have been a recurring subject in comparative endocrinology and receptor pharmacology, where the corresponding receptors are studied as G-protein-coupled receptors.

Where Does It Come From?

The anatomical unit usually described is the hypothalamo-neurohypophysial system. Peptide precursors are produced in hypothalamic magnocellular neurons together with carrier proteins called neurophysins, packaged into secretory granules, and transported along axons that terminate in the posterior pituitary. Release occurs when those terminals are depolarised, so a neurohypophysial hormone is a neurosecretory product: a peptide made by neurons but acting as a circulating hormone.

Secretion at the terminal is not described as a purely neuronal event. A 2009 paper in Glia examined pituicytes — the specialised glial cells of the neurohypophysis — and reported that these cells can modulate neurohormone output from the posterior pituitary, positioning glia as an active participant in how much peptide leaves the gland (PMID 18803308).

How the Term Is Used in Peptide Research

In the literature, "neurohypophysial hormone" appears in three broad settings.

• Comparative endocrinology. The term groups vasopressin, oxytocin and their non-mammalian homologues so that sequences, receptors and signalling can be compared across vertebrate lineages.
• Receptor nomenclature. "Neurohypophysial hormone receptor" is used as a family name for the vasopressin-type and oxytocin-type receptors, particularly in species where mammalian V1/V2/OT labels do not map cleanly.
• Secretion physiology. The phrase "neurohypophysial function" is used when researchers describe release of the hormones as a system-level output — for example under osmotic stimulation, stress, or across the day-night cycle — rather than tracking one peptide alone.

Structural analogues of these peptides also exist as approved human medicines in several countries (for example synthetic vasopressin and oxytocin analogues used in hospital settings), which is one reason the family is frequently referenced in peptide chemistry discussions. This page does not describe administration, protocols or amounts for any such product.

What the Published Literature Reports

Receptors across vertebrate lineages

A 2006 report in Comparative Biochemistry and Physiology Part B described the cloned avian neurohypophysial hormone receptors and reported that birds express multiple receptor subtypes for vasotocin and mesotocin, which the authors compared with mammalian vasopressin and oxytocin receptors (PMID 16311051). Extending the comparison to the most basal vertebrates, a 2023 study in General and Comparative Endocrinology characterised hagfish neurohypophysial hormone receptors and reported phylogenetic and functional properties that were distinct from their jawed-vertebrate counterparts (PMID 36868365). Together these papers illustrate why the receptor family is treated as an evolutionary series rather than a fixed mammalian scheme.

Peripheral target tissues

Work in fish showed that the family's receptors are not confined to kidney, vasculature or reproductive tissue. A 2000 paper in The Journal of Endocrinology examined trout hepatocytes and reported neurohypophysial hormone receptors and associated second-messenger responses in those liver cells, indicating a hepatic target for vasotocin- and isotocin-type signalling in that species (PMID 11018761).

Timing of release

A 2000 review in Experimental Physiology surveyed diurnal rhythms in neurohypophysial function and reported that release of these hormones varies across the light-dark cycle rather than remaining constant (PMID 10795921). Following that theme in humans, a 2002 study in Clinical Endocrinology gave exogenous melatonin to volunteers and measured stimulated neurohypophysial hormone release, reporting on whether melatonin altered the stimulated secretory response (PMID 12390335). Readers wanting the exact stimulus, quantities and outcome measures should consult the paper itself; those specifics are not reproduced here.

Common Points of Confusion

• Neurohypophysial versus adenohypophysial. Adenohypophysial (anterior pituitary) hormones such as growth hormone, ACTH, TSH, LH, FSH and prolactin are made by glandular cells in the anterior lobe. Neurohypophysial hormones are made in the hypothalamus and merely stored and released in the posterior lobe, so the two groups differ in origin as well as chemistry.
• It is not one molecule. A search result or label reading "neurohypophysial hormone" does not identify a specific peptide; the species and the family line (vasopressin-type or oxytocin-type) determine which molecule is meant.
• Receptor names vary by species. The same ligand family can be assigned different receptor nomenclature in birds, fish and cyclostomes, which is why comparative papers such as the avian and hagfish reports above use the umbrella term (PMID 16311051, PMID 36868365).

Limits of the Evidence Summarised Here

The papers cited on this page are mostly comparative, cellular or physiological studies: receptor cloning and characterisation in birds, fish and hagfish, glial modulation of secretion in the posterior pituitary, a review of daily rhythms, and one small human study of stimulated release. They define what the term means and how the system behaves under laboratory conditions; they do not establish clinical outcomes, and none of them describes recreational or self-directed use of any peptide. Findings in fish, birds or rodents do not transfer automatically to humans, and single studies are starting points rather than conclusions.

This page is for educational purposes only and is not medical advice; consult a licensed physician or qualified healthcare professional about any medical question, symptom or treatment decision. Nothing here should be read as a suggestion to obtain or use any substance.

References

• Phylogenetic and functional properties of hagfish neurohypophysial hormone receptors distinct from their jawed vertebrate counterparts (General and Comparative Endocrinology, 2023)
• Diurnal rhythms in neurohypophysial function (Experimental Physiology, 2000)
• The effect of exogenous melatonin on stimulated neurohypophysial hormone release in man (Clinical Endocrinology, 2002)
• Pituicyte modulation of neurohormone output (Glia, 2009)
• The cloned avian neurohypophysial hormone receptors (Comparative Biochemistry and Physiology Part B, 2006)
• Neurohypophysial hormone receptors and second messengers in trout hepatocytes (The Journal of Endocrinology, 2000)